Osteopontin is a prognostic biomarker in non-small cell lung cancer
Abstract Background In a previously published report we characterized the expression of the metastasis-associated proteins S100A4, osteopontin (OPN) and ephrin-A1 in a prospectively collected panel of non-small cell lung cancer (NSCLC) tumors. The aim of the present follow-up study was to investigat...
Saved in:
| Main Authors: | Ane Kongsgaard, Kjetil Boye, Miriam Øijordsbakken, Marius Lund-Iversen, Ann Rita Halvorsen, Steinar K Solberg, Gisle Berge, Åslaug Helland, Odd Terje Brustugun, Gunhild M Mælandsmo |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2013-11-01
|
| Series: | BMC Cancer |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/1471-2407-13-540 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Detection of disseminated tumor cells in lymph nodes from patients with early stage non-small cell lung cancer
by: Ane Kongsgaard, et al.
Published: (2016-06-01) -
The immune microenvironment in non‐small cell lung cancer is predictive of prognosis after surgery
by: Åsa Kristina Öjlert, et al.
Published: (2019-05-01) -
Overexpression of Osteopontin-a and Osteopontin-c Splice Variants Are Worse Prognostic Features in Colorectal Cancer
by: Daniella Mattos, et al.
Published: (2024-09-01) -
The association of osteopontin gene variant rs1126616, circulating osteopontin and urinary TWEAK levels with systemic lupus erythematosus disease and lupus nephritis in a group of Egyptian patients: case–control study
by: Hala Ashraf, et al.
Published: (2025-06-01) -
Osteopontin as a biomarker for diagnosing the severity of osteoarthritis
by: M. A. Taha, et al.
Published: (2024-10-01)